Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Stanford University230 enrolled

Overview

The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Study Type

OBSERVATIONAL

Enrollment

230

Conditions

Corona Virus Infection Flu Vaccine Immunity

Interventions

Flu shotBIOLOGICAL

All participants will receive a single shot of the flu vaccine

Eligibility

Sex: ALLMin age: 9 YearsMax age: 64 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age 9 through 64 years * Diagnosed with COVID-19 at least 2 months prior enrollment * Patients with or without obesity, diabetes, chronic fatigue and/or long term COVID-19 symptoms * Patients without COVID-19 diagnosis for controls Exclusion Criteria: * Received the influenza vaccine less than 4 months ago * Pregnant or lactating * Patients with special risks attendant to venipuncture * Use of immunomodulatory medications that may impact vaccine immune response per clinician's judgment * Contraindication to the flu vaccine * Immunodeficiency or autoimmune disease that may impact vaccine immune responses per clinician's judgement

Locations (1)

Stanford University

Palo Alto, California, United States

RECRUITING

Outcomes

Primary Outcomes

Testing immunity to the flu vaccine over time

Time frame: 1 week

Testing immunity to the flu vaccine over time

Time frame: 1 month

Central Contacts

SNP Center Inquiry

CONTACT

(650) 521-7237 snpcenterallergy_inquiry@stanford.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.